搜尋結果
A corner of the cancer therapy market is heating up—Here are the names investors need to know ...
CNBC· 1 日前There's been a lot of attention lately on a corner of ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 1 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on< ...
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 13 小時前Eli Lilly will invest the funds to develop a manufacturing plant in Lebanon, Indiana ... ...
First Zantac Cancer Case to Go to Trial Ends in Win for Drugmakers
Bloomberg· 1 日前Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
CNBC· 3 日前Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing & ...
Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earnings
CNBC· 3 小時前ET. 1. Wall Street was bouncing higher Friday after, as Jim Cramer put it, a "really bad ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters· 24 小時前A jury in Chicago on Thursday rejected an Illinois woman’s claim that the ...
Jefferies says small caps are starting to outperform and these stocks are the best way to play ...
CNBC· 4 小時前the sun, according to Jefferies. Nvidia , Wall Street's poster child of the artificial ...
Beijing drug manufacturer aiming to develop liver fibrosis drug
China Daily· 1 日前In addition to focusing on the development and commercialization of hydronidone for ... ...
China Market Update: Alibaba & JD Offer Convertible Bonds, “Healthy” Correction Continues, Week ...
Forbes· 13 小時前Asian equities were a sea of red overnight as investors grapple with higher for longer rates, as < ...